We demonstrated with flow cytometry (FACS) immunophenotyping that after pCons treatment the CD19+CD1d+ regulatory B cell subset was significantly increased in BWF1 lupus mice compared to naïve mice (Figures 4B, G, D). This evidence concerns the gene CD1D and systemic lupus erythematosus.